| endocrine system development | GO:0035270 | 26 | 0.768 | Human |
| neuron fate commitment | GO:0048663 | 2 | 0.730 | |
| extraocular skeletal muscle development | GO:0002074 | 1 | 0.729 | |
| specification of organ identity | GO:0010092 | 3 | 0.706 | |
| organ morphogenesis | GO:0009887 | 147 | 0.706 | Human |
| regulation of heart induction by regulation of canonical wnt signaling pathway | GO:0090081 | 1 | 0.688 | |
| cardiac cell fate determination | GO:0060913 | 3 | 0.687 | Human |
| cell cell signaling | GO:0007267 | 155 | 0.685 | |
| tube development | GO:0035295 | 125 | 0.676 | Human |
| cell fate determination | GO:0001709 | 3 | 0.611 | Human |
| regulation of cell differentiation | GO:0045595 | 393 | 0.564 | Human |
| embryonic morphogenesis | GO:0048598 | 85 | 0.555 | Human |
| circulatory system development | GO:0072359 | 262 | 0.543 | Human |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.543 | |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.535 | |
| forebrain regionalization | GO:0021871 | 3 | 0.531 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.523 | Human |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.522 | Human |
| hindbrain development | GO:0030902 | 3 | 0.522 | |
| stem cell differentiation | GO:0048863 | 93 | 0.507 | Human |
| cell development | GO:0048468 | 328 | 0.494 | Human |
| bmp signaling pathway involved in heart development | GO:0061312 | 3 | 0.492 | |
| stem cell development | GO:0048864 | 69 | 0.490 | Human |
| tube morphogenesis | GO:0035239 | 95 | 0.474 | Human |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.459 | Human |
| cardiovascular system development | GO:0072358 | 262 | 0.453 | Human |
| forebrain development | GO:0030900 | 26 | 0.449 | Human |
| skeletal system development | GO:0001501 | 79 | 0.441 | Human |
| nervous system development | GO:0007399 | 293 | 0.436 | Human |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.436 | Human |
| positive regulation of aldosterone metabolic process | GO:0032346 | 2 | 0.424 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.412 | Human |
| mesenchyme development | GO:0060485 | 59 | 0.410 | |
| cell differentiation in spinal cord | GO:0021515 | 1 | 0.406 | |
| organ formation | GO:0048645 | 3 | 0.403 | |
| cell morphogenesis | GO:0000902 | 296 | 0.402 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.399 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.393 | |
| generation of neurons | GO:0048699 | 152 | 0.375 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.363 | |
| digestive tract development | GO:0048565 | 75 | 0.340 | Human |
| brain development | GO:0007420 | 97 | 0.331 | Human |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.329 | |
| regulation of locomotion | GO:0040012 | 329 | 0.323 | Human |
| epithelium development | GO:0060429 | 227 | 0.316 | Human |
| vasculature development | GO:0001944 | 181 | 0.316 | Human |
| negative regulation of cell development | GO:0010721 | 48 | 0.315 | Human |
| regulation of hormone levels | GO:0010817 | 125 | 0.315 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.302 | Human |
| head development | GO:0060322 | 108 | 0.290 | Human |
| neurogenesis | GO:0022008 | 169 | 0.280 | Human |
| forebrain generation of neurons | GO:0021872 | 3 | 0.280 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.277 | |
| cell projection organization | GO:0030030 | 252 | 0.273 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.270 | Human |
| regulation of cell cycle | GO:0051726 | 393 | 0.267 | Human |
| neuron projection development | GO:0031175 | 106 | 0.267 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.263 | |
| metencephalon development | GO:0022037 | 2 | 0.260 | |
| positive regulation of aldosterone biosynthetic process | GO:0032349 | 2 | 0.258 | |
| central nervous system development | GO:0007417 | 123 | 0.257 | Human |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.248 | Human |
| ion transmembrane transport | GO:0034220 | 338 | 0.245 | |
| neuron differentiation | GO:0030182 | 138 | 0.245 | Human |
| tissue morphogenesis | GO:0048729 | 96 | 0.245 | |
| segmentation | GO:0035282 | 4 | 0.242 | |
| secretion by cell | GO:0032940 | 226 | 0.239 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.236 | Human |
| hormone secretion | GO:0046879 | 65 | 0.236 | |
| positive regulation of transport | GO:0051050 | 336 | 0.233 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.224 | Human |
| menstrual cycle phase | GO:0022601 | 2 | 0.222 | |
| digestive system development | GO:0055123 | 75 | 0.222 | Human |
| regulation of cell development | GO:0060284 | 161 | 0.218 | Human |
| heart formation | GO:0060914 | 2 | 0.209 | |
| regulation of secretion | GO:0051046 | 194 | 0.208 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.205 | Human |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.202 | |
| pancreas development | GO:0031016 | 19 | 0.197 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.194 | Human |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.191 | Human |
| secretion | GO:0046903 | 254 | 0.190 | |
| post embryonic development | GO:0009791 | 2 | 0.189 | |
| heart morphogenesis | GO:0003007 | 48 | 0.184 | |
| system process | GO:0003008 | 349 | 0.184 | |
| cerebellum development | GO:0021549 | 2 | 0.184 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.175 | Human |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.175 | Human |
| regulation of secretion by cell | GO:1903530 | 177 | 0.173 | |
| regulation of protein transport | GO:0051223 | 213 | 0.171 | Human |
| cytoplasmic transport | GO:0016482 | 379 | 0.170 | Human |
| regulation of cellular component movement | GO:0051270 | 334 | 0.168 | Human |
| positive regulation of developmental process | GO:0051094 | 314 | 0.162 | Human |
| regulation of methylation dependent chromatin silencing | GO:0090308 | 3 | 0.157 | |
| cardiac right ventricle morphogenesis | GO:0003215 | 3 | 0.155 | |
| inner ear morphogenesis | GO:0042472 | 4 | 0.154 | |
| regulation of cell motility | GO:2000145 | 299 | 0.154 | Human |
| spinal cord development | GO:0021510 | 4 | 0.152 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.149 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.146 | |
| canonical wnt signaling pathway involved in cardiac muscle cell fate commitment | GO:0061317 | 3 | 0.145 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.142 | |
| cell proliferation in forebrain | GO:0021846 | 1 | 0.142 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.141 | |
| urogenital system development | GO:0001655 | 65 | 0.140 | Human |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.138 | |
| locomotory behavior | GO:0007626 | 1 | 0.138 | |
| positive regulation of tooth mineralization | GO:0070172 | 2 | 0.137 | |
| sensory organ development | GO:0007423 | 52 | 0.135 | Human |
| sensory organ morphogenesis | GO:0090596 | 21 | 0.135 | |
| pattern specification process | GO:0007389 | 43 | 0.133 | |
| oxidative stress induced premature senescence | GO:0090403 | 3 | 0.132 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.132 | |
| soft palate development | GO:0060023 | 3 | 0.129 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.127 | |
| regulation of male gonad development | GO:2000018 | 4 | 0.127 | Human |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.127 | Human |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.122 | |
| regulation of neuron differentiation | GO:0045664 | 70 | 0.121 | Human |
| signal release | GO:0023061 | 70 | 0.121 | |
| endodermal cell fate commitment | GO:0001711 | 4 | 0.119 | Human |
| formation of primary germ layer | GO:0001704 | 42 | 0.117 | Human |
| cell projection morphogenesis | GO:0048858 | 129 | 0.117 | |
| endodermal mesodermal cell signaling | GO:0003133 | 3 | 0.116 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 2 | 0.114 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.113 | Human |
| mesonephric duct development | GO:0072177 | 3 | 0.112 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.112 | |
| heart development | GO:0007507 | 95 | 0.112 | Human |
| immune system development | GO:0002520 | 195 | 0.111 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.111 | |
| blood vessel development | GO:0001568 | 172 | 0.111 | Human |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.110 | Human |
| sex determination | GO:0007530 | 3 | 0.109 | Human |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.108 | Human |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.108 | Human |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.106 | |
| heart process | GO:0003015 | 62 | 0.105 | |
| negative regulation of testicular blood vessel morphogenesis | GO:0061369 | 1 | 0.105 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.105 | Human |
| response to abiotic stimulus | GO:0009628 | 336 | 0.104 | |
| regulation of protein localization | GO:0032880 | 296 | 0.101 | Human |
| regulation of proteolysis | GO:0030162 | 293 | 0.101 | Human |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.101 | |
| globus pallidus development | GO:0021759 | 1 | 0.099 | |
| amine metabolic process | GO:0009308 | 44 | 0.098 | |
| dermatome development | GO:0061054 | 3 | 0.098 | |
| regulation of neurogenesis | GO:0050767 | 82 | 0.098 | Human |
| regulation of nervous system development | GO:0051960 | 88 | 0.098 | Human |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.098 | |
| neural crest cell development | GO:0014032 | 3 | 0.097 | |
| chromatin organization | GO:0006325 | 351 | 0.096 | Human |
| positive regulation of steroid hormone biosynthetic process | GO:0090031 | 2 | 0.096 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.095 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 43 | 0.095 | |
| neuron development | GO:0048666 | 113 | 0.094 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.093 | Human |
| regionalization | GO:0003002 | 29 | 0.093 | |
| negative regulation of transport | GO:0051051 | 176 | 0.093 | Human |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.092 | Human |
| chromatin modification | GO:0016568 | 298 | 0.091 | Human |
| luteinizing hormone secretion | GO:0032275 | 1 | 0.091 | |
| response to lipid | GO:0033993 | 206 | 0.090 | Human |
| regulation of cell migration | GO:0030334 | 289 | 0.090 | Human |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.089 | Human |
| canonical wnt signaling pathway involved in mesenchymal stem cell differentiation | GO:0044338 | 2 | 0.089 | |
| bmp signaling pathway | GO:0030509 | 49 | 0.087 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.087 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.087 | Human |
| neuroblast proliferation | GO:0007405 | 4 | 0.087 | |
| negative regulation of neurogenesis | GO:0050768 | 26 | 0.086 | Human |
| eye development | GO:0001654 | 42 | 0.085 | Human |
| hard palate development | GO:0060022 | 1 | 0.085 | |
| ventral spinal cord development | GO:0021517 | 1 | 0.085 | |
| cell fate commitment | GO:0045165 | 27 | 0.085 | Human |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.085 | |
| growth | GO:0040007 | 202 | 0.084 | Human |
| chemical homeostasis | GO:0048878 | 306 | 0.083 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.083 | Human |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.083 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.083 | |
| epithelial to mesenchymal transition | GO:0001837 | 48 | 0.082 | |
| response to wounding | GO:0009611 | 168 | 0.082 | Human |
| regulation of system process | GO:0044057 | 101 | 0.082 | |
| taxis | GO:0042330 | 157 | 0.082 | |
| regulation of organ morphogenesis | GO:2000027 | 24 | 0.081 | |
| forelimb morphogenesis | GO:0035136 | 4 | 0.080 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 4 | 0.080 | |
| embryo development | GO:0009790 | 123 | 0.080 | Human |
| embryonic forelimb morphogenesis | GO:0035115 | 4 | 0.079 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.078 | |
| heart field specification | GO:0003128 | 2 | 0.078 | |
| positive regulation of hormone biosynthetic process | GO:0046886 | 4 | 0.078 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.078 | |
| chemotaxis | GO:0006935 | 157 | 0.076 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 2 | 0.076 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.075 | |
| regulation of hormone secretion | GO:0046883 | 57 | 0.075 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.074 | |
| limbic system development | GO:0021761 | 3 | 0.074 | |
| embryonic camera type eye development | GO:0031076 | 2 | 0.073 | |
| cardiac ventricle formation | GO:0003211 | 2 | 0.072 | |
| cartilage condensation | GO:0001502 | 1 | 0.072 | |
| paramesonephric duct development | GO:0061205 | 2 | 0.072 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.072 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.072 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.071 | |
| protein localization to organelle | GO:0033365 | 280 | 0.071 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.071 | Human |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.071 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.070 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.070 | |
| pituitary gland development | GO:0021983 | 2 | 0.070 | Human |
| aortic valve development | GO:0003176 | 3 | 0.070 | |
| endoderm formation | GO:0001706 | 33 | 0.069 | Human |
| endoderm development | GO:0007492 | 33 | 0.069 | Human |
| neuron projection morphogenesis | GO:0048812 | 50 | 0.069 | |
| mesonephros development | GO:0001823 | 17 | 0.068 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.068 | Human |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.068 | Human |
| somatostatin receptor signaling pathway | GO:0038169 | 1 | 0.067 | |
| positive regulation of glucocorticoid biosynthetic process | GO:0031948 | 1 | 0.067 | |
| limb bud formation | GO:0060174 | 1 | 0.067 | |
| positive regulation of epithelial cell proliferation involved in wound healing | GO:0060054 | 3 | 0.066 | |
| lipid metabolic process | GO:0006629 | 381 | 0.066 | |
| canonical wnt signaling pathway involved in osteoblast differentiation | GO:0044339 | 2 | 0.066 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.065 | |
| negative regulation of posttranscriptional gene silencing | GO:0060149 | 3 | 0.065 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.064 | Human |
| somatostatin signaling pathway | GO:0038170 | 1 | 0.063 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.063 | Human |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.063 | Human |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.063 | Human |
| forebrain neuron development | GO:0021884 | 2 | 0.062 | |
| positive regulation of odontogenesis | GO:0042482 | 3 | 0.062 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.062 | Human |
| regulation of multi organism process | GO:0043900 | 157 | 0.062 | |
| positive regulation of glucocorticoid secretion | GO:2000851 | 4 | 0.061 | |
| response to alcohol | GO:0097305 | 64 | 0.061 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.061 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.061 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.061 | Human |
| negative regulation of cell migration | GO:0030336 | 102 | 0.061 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.060 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.060 | Human |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.060 | Human |
| hormone transport | GO:0009914 | 68 | 0.059 | |
| neuroendocrine cell differentiation | GO:0061101 | 2 | 0.059 | |
| positive regulation of glucocorticoid metabolic process | GO:0031945 | 1 | 0.059 | |
| immune response | GO:0006955 | 307 | 0.059 | |
| kidney morphogenesis | GO:0060993 | 19 | 0.058 | |
| positive regulation of cortisol biosynthetic process | GO:2000066 | 1 | 0.058 | |
| chordate embryonic development | GO:0043009 | 34 | 0.057 | |
| regulation of heart induction | GO:0090381 | 2 | 0.057 | |
| response to hormone | GO:0009725 | 175 | 0.057 | |
| transmembrane transport | GO:0055085 | 399 | 0.057 | |
| gland development | GO:0048732 | 48 | 0.057 | Human |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.057 | |
| kidney epithelium development | GO:0072073 | 25 | 0.056 | |
| neurological system process | GO:0050877 | 163 | 0.056 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.056 | |
| intracellular protein transport | GO:0006886 | 270 | 0.056 | Human |
| motor neuron axon guidance | GO:0008045 | 2 | 0.055 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.055 | Human |
| regulation of dermatome development | GO:0061183 | 3 | 0.055 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.055 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.055 | Human |
| kidney development | GO:0001822 | 53 | 0.055 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.055 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.054 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.054 | Human |
| muscle contraction | GO:0006936 | 73 | 0.054 | |
| menstruation | GO:0042703 | 1 | 0.054 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.054 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 37 | 0.053 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.053 | |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.053 | |
| embryonic organ development | GO:0048568 | 36 | 0.053 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.052 | Human |
| monovalent inorganic cation transport | GO:0015672 | 128 | 0.052 | |
| hemopoiesis | GO:0030097 | 180 | 0.052 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.052 | Human |
| muscle structure development | GO:0061061 | 98 | 0.052 | |
| bmp signaling pathway involved in heart induction | GO:0003130 | 3 | 0.052 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.051 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.051 | |
| adenylate cyclase inhibiting opioid receptor signaling pathway | GO:0031635 | 1 | 0.051 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.051 | |
| negative regulation of cytosolic calcium ion concentration | GO:0051481 | 1 | 0.051 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.051 | Human |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.050 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.050 | |
| regulation of growth | GO:0040008 | 165 | 0.050 | Human |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.050 | Human |
| regulation of cell cycle process | GO:0010564 | 266 | 0.050 | Human |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.050 | Human |
| camera type eye development | GO:0043010 | 25 | 0.049 | |
| cell division | GO:0051301 | 168 | 0.049 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.049 | Human |
| cranial nerve development | GO:0021545 | 4 | 0.049 | |
| female gamete generation | GO:0007292 | 2 | 0.049 | |
| neural tube patterning | GO:0021532 | 2 | 0.049 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.049 | |
| steroid metabolic process | GO:0008202 | 94 | 0.049 | |
| ventral spinal cord interneuron differentiation | GO:0021514 | 1 | 0.049 | |
| circulatory system process | GO:0003013 | 113 | 0.048 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.048 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.048 | |
| cyclic nucleotide metabolic process | GO:0009187 | 82 | 0.048 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.047 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.047 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.047 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.047 | Human |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.046 | Human |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.046 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.046 | |
| regulation of ion transmembrane transport | GO:0034765 | 132 | 0.046 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.045 | |
| cerebral cortex cell migration | GO:0021795 | 3 | 0.045 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.045 | Human |
| single organism cellular localization | GO:1902580 | 332 | 0.045 | |
| positive regulation of insulin like growth factor receptor signaling pathway | GO:0043568 | 4 | 0.045 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.045 | |
| right ventricular cardiac muscle tissue morphogenesis | GO:0003221 | 2 | 0.045 | |
| mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0003337 | 4 | 0.045 | |
| reproductive system development | GO:0061458 | 56 | 0.045 | Human |
| central nervous system neuron differentiation | GO:0021953 | 9 | 0.044 | |
| muscle system process | GO:0003012 | 81 | 0.044 | |
| protein import into nucleus | GO:0006606 | 104 | 0.044 | |
| nephron tubule morphogenesis | GO:0072078 | 13 | 0.044 | |
| regulation of ion transport | GO:0043269 | 189 | 0.044 | |
| potassium ion transmembrane transport | GO:0071805 | 60 | 0.044 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.044 | |
| oogenesis | GO:0048477 | 2 | 0.044 | |
| thymus development | GO:0048538 | 3 | 0.044 | |
| cation transport | GO:0006812 | 331 | 0.043 | |
| pharynx development | GO:0060465 | 1 | 0.043 | |
| positive regulation of nervous system development | GO:0051962 | 54 | 0.043 | Human |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.043 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.043 | Human |
| cell fate commitment involved in pattern specification | GO:0060581 | 1 | 0.043 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.043 | |
| regulation of muscle contraction | GO:0006937 | 45 | 0.043 | |
| cardiac chamber formation | GO:0003207 | 2 | 0.043 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.043 | Human |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.042 | Human |
| positive regulation of cell death | GO:0010942 | 263 | 0.042 | Human |
| gastrulation | GO:0007369 | 51 | 0.042 | Human |
| single organism reproductive process | GO:0044702 | 98 | 0.042 | Human |
| reproductive process | GO:0022414 | 106 | 0.042 | Human |
| response to organonitrogen compound | GO:0010243 | 156 | 0.042 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.041 | |
| nephron epithelium development | GO:0072009 | 23 | 0.041 | |
| cell growth | GO:0016049 | 160 | 0.041 | Human |
| neurotransmitter secretion | GO:0007269 | 4 | 0.041 | |
| negative regulation of gene silencing by rna | GO:0060967 | 3 | 0.041 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.041 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.041 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.041 | |
| regulation of ossification | GO:0030278 | 58 | 0.040 | Human |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.040 | Human |
| positive regulation of protein transport | GO:0051222 | 135 | 0.040 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.040 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.040 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.040 | |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.040 | Human |
| positive regulation of cell motility | GO:2000147 | 177 | 0.040 | Human |
| negative regulation of nervous system development | GO:0051961 | 28 | 0.040 | Human |
| metanephros development | GO:0001656 | 16 | 0.040 | |
| muscle tissue development | GO:0060537 | 62 | 0.040 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.040 | |
| nephron morphogenesis | GO:0072028 | 15 | 0.039 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.039 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.039 | Human |
| embryonic camera type eye formation | GO:0060900 | 2 | 0.039 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.039 | |
| blood circulation | GO:0008015 | 113 | 0.039 | |
| negative regulation of stem cell differentiation | GO:2000737 | 22 | 0.039 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.039 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.038 | |
| regulation of organ formation | GO:0003156 | 4 | 0.038 | |
| renal system development | GO:0072001 | 63 | 0.038 | Human |
| response to growth factor | GO:0070848 | 205 | 0.038 | Human |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.038 | Human |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.038 | |
| second messenger mediated signaling | GO:0019932 | 78 | 0.038 | Human |
| ureteric bud development | GO:0001657 | 13 | 0.037 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.037 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.037 | |
| bone mineralization | GO:0030282 | 34 | 0.037 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.037 | Human |
| regulation of heart contraction | GO:0008016 | 50 | 0.037 | |
| epithelium migration | GO:0090132 | 119 | 0.037 | Human |
| metal ion transport | GO:0030001 | 272 | 0.037 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.037 | |
| nuclear transport | GO:0051169 | 179 | 0.037 | Human |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.036 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.036 | Human |
| startle response | GO:0001964 | 3 | 0.036 | |
| regulation of blood circulation | GO:1903522 | 59 | 0.035 | |
| positive regulation of neurogenesis | GO:0050769 | 49 | 0.035 | Human |
| blastoderm segmentation | GO:0007350 | 2 | 0.035 | |
| cardiac muscle cell contraction | GO:0086003 | 4 | 0.035 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 109 | 0.035 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.035 | |
| regulation of cardiac muscle contraction | GO:0055117 | 33 | 0.035 | |
| morphogenesis of a branching epithelium | GO:0061138 | 20 | 0.035 | |
| single organism nuclear import | GO:1902593 | 104 | 0.035 | |
| cellular homeostasis | GO:0019725 | 196 | 0.035 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.035 | |
| protein targeting | GO:0006605 | 187 | 0.035 | |
| synaptic transmission | GO:0007268 | 61 | 0.034 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.034 | Human |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.034 | |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.034 | |
| action potential | GO:0001508 | 34 | 0.034 | |
| heart induction | GO:0003129 | 4 | 0.034 | |
| wnt signaling pathway involved in wound healing spreading of epidermal cells | GO:0035659 | 1 | 0.034 | |
| embryonic organ morphogenesis | GO:0048562 | 24 | 0.034 | |
| ribonucleotide biosynthetic process | GO:0009260 | 81 | 0.034 | |
| actin filament based process | GO:0030029 | 224 | 0.034 | |
| memory | GO:0007613 | 3 | 0.034 | |
| rostrocaudal neural tube patterning | GO:0021903 | 1 | 0.033 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.033 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.033 | Human |
| pulmonary vein morphogenesis | GO:0060577 | 1 | 0.033 | |
| axonogenesis | GO:0007409 | 31 | 0.033 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.033 | |
| positive regulation of dermatome development | GO:0061184 | 3 | 0.033 | |
| negative regulation of gene silencing by mirna | GO:0060965 | 3 | 0.033 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 98 | 0.033 | Human |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.033 | |
| hormone metabolic process | GO:0042445 | 61 | 0.033 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.033 | |
| angiogenesis | GO:0001525 | 147 | 0.033 | Human |
| blood vessel maturation | GO:0001955 | 1 | 0.032 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.032 | |
| steroid biosynthetic process | GO:0006694 | 46 | 0.032 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.032 | Human |
| regulation of antimicrobial humoral response | GO:0002759 | 1 | 0.032 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.032 | Human |
| regulation of cell projection organization | GO:0031344 | 107 | 0.032 | |
| endodermal cell differentiation | GO:0035987 | 31 | 0.032 | Human |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.032 | |
| sensory perception | GO:0007600 | 103 | 0.032 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 61 | 0.032 | |
| skin development | GO:0043588 | 76 | 0.032 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.032 | |
| regulation of heart morphogenesis | GO:2000826 | 4 | 0.032 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.032 | Human |
| ion homeostasis | GO:0050801 | 230 | 0.032 | |
| reproductive structure development | GO:0048608 | 55 | 0.032 | Human |
| peptide secretion | GO:0002790 | 51 | 0.032 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.031 | Human |
| cd8 positive alpha beta t cell differentiation involved in immune response | GO:0002302 | 1 | 0.031 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.031 | |
| methylation dependent chromatin silencing | GO:0006346 | 3 | 0.031 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.031 | Human |
| negative regulation of wnt protein secretion | GO:0061358 | 1 | 0.031 | |
| mapk cascade | GO:0000165 | 288 | 0.031 | Human |
| branching morphogenesis of an epithelial tube | GO:0048754 | 19 | 0.031 | |
| regulation of protein localization to nucleus | GO:1900180 | 85 | 0.031 | |
| cell aggregation | GO:0098743 | 1 | 0.031 | |
| tissue migration | GO:0090130 | 119 | 0.031 | Human |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.031 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.031 | Human |
| male sex differentiation | GO:0046661 | 25 | 0.031 | Human |
| nerve development | GO:0021675 | 4 | 0.031 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.031 | |
| protein targeting to nucleus | GO:0044744 | 104 | 0.031 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.031 | Human |
| endodermal mesodermal cell signaling involved in heart induction | GO:0003134 | 3 | 0.031 | |
| renal tubule development | GO:0061326 | 19 | 0.031 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.030 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.030 | |
| nephron epithelium morphogenesis | GO:0072088 | 15 | 0.030 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.030 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.030 | |
| positive regulation of lipid metabolic process | GO:0045834 | 50 | 0.030 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.030 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.030 | |
| oxidation reduction process | GO:0055114 | 396 | 0.030 | |
| response to steroid hormone | GO:0048545 | 80 | 0.030 | |
| cardiac left ventricle formation | GO:0003218 | 1 | 0.030 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 82 | 0.030 | |
| connective tissue development | GO:0061448 | 39 | 0.030 | Human |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.030 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.030 | |
| purine containing compound biosynthetic process | GO:0072522 | 88 | 0.030 | |
| neural crest cell migration | GO:0001755 | 2 | 0.029 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.029 | |
